Skip to main content
Figure 3 | Critical Care

Figure 3

From: Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial

Figure 3

Norepinephrine duration for patients treated with low-dose hydrocortisone and placebo. Thirty-two severely burned patients were initially randomized in this clinical trial evaluating the effect of low-dose hydrocortisone on shock duration after burn. Twelve low-dose hydrocortisone-treated patients (corticosteroids, grey boxes) and 15 patients treated with placebo (placebo, open boxes) were finally included in the statistical analysis. Box plots and individual values of norepinephrine duration (in hours) in low-dose hydrocortisone and placebo-treated groups are presented. Differences between groups were evaluated by using the Mann-Whitney test.

Back to article page